The trial’s new health status analysis gives even more reason to consider CABG the preferred revascularization strategy for patients with anatomically complex three-vessel or left main disease.
ABSORB III at Two Years: Jury’s Still Out on Bioresorbable Stent Vs. DES
Lead investigator of the pivotal study of the new bioresorbable stent explains the nuanced interim results (straight from ACC.17) and what to expect next.
IVUS-Guided PCI in the Era of Drug-Eluting Stents
A new meta-analysis shows IVUS’ edge over angiography for guiding stent placement extends to drug-eluting stents as well as bare-metal stents. But that doesn’t mean IVUS makes sense for lower-risk patients.
Coronary Brachytherapy: Still Relevant in the Era of Drug-Eluting Stents
Adjunctive intracoronary radiation therapy is a treatment modality that still has value even in the era of drug-eluting stents. Vascular brachytherapy is now an option again at Cleveland Clinic in carefully selected patients.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy